| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $3.18 ▲ +4.61% | Yesterday | $3.05 ▼ -0.33% | Tomorrow's Recursion Pharmaceuticals Inc. Class A Common Stock (RXRX) setup is anchored to $3.04 and targets $3.18 (+4.61%). The near-term read is upside; watch $3.88 / $2.98 because daily realized volatility is about 3.55%. |
Tomorrow's Recursion Pharmaceuticals Inc. Class A Common Stock (RXRX) setup is anchored to $3.04 and targets $3.18 (+4.61%). The near-term read is upside; watch $3.88 / $2.98 because daily realized volatility is about 3.55%. | ||||
| Week | $3.36 ▲ +10.53% | Last Week | $3.32 ▼ -8.43% | The 7-day Recursion Pharmaceuticals Inc. Class A Common Stock model moves from $3.32 to $3.36 (+10.53%). It gives upside momentum context for this stock, so breaks around $3.88 / $2.98 matter more than a single tick. |
The 7-day Recursion Pharmaceuticals Inc. Class A Common Stock model moves from $3.32 to $3.36 (+10.53%). It gives upside momentum context for this stock, so breaks around $3.88 / $2.98 matter more than a single tick. | ||||
| Month | $3.57 ▲ +17.43% | Last Month | $3.75 ▼ -18.93% | The 1-month Recursion Pharmaceuticals Inc. Class A Common Stock target is $3.57 (+17.43%), compared with the live reference near $3.04. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Recursion Pharmaceuticals Inc. Class A Common Stock target is $3.57 (+17.43%), compared with the live reference near $3.04. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $3.82 ▲ +25.66% | Last Year | $4.25 ▼ -28.47% | The 1-year Recursion Pharmaceuticals Inc. Class A Common Stock scenario points to $3.82 (+25.66%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Recursion Pharmaceuticals Inc. Class A Common Stock scenario points to $3.82 (+25.66%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $4.36 ▲ +43.42% | 5 Years Ago | $21.18 ▼ -85.65% | The 5-year Recursion Pharmaceuticals Inc. Class A Common Stock view is $4.36 (+43.42%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Recursion Pharmaceuticals Inc. Class A Common Stock view is $4.36 (+43.42%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 5.4 | Bearish |
| MACD | 0.10 | Bullish |
| SMA 50 | $3.27 | Mid |
| SMA 200 | $5.42 | Mid |
| EMA 20 | $6.37 | Mid |
| Opening Price | $3.13 | Start Date | 2021-04-16 |
| Day Range | $3.03 – $3.21 | Market Cap | $1.88B |
| Monthly Range | $3.04 – $3.78 | 24h Volume | n/a |
| 90D Range | $2.84 – $4.96 | Circulating | n/a |
| 52W Range | $2.84 – $10.87 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.